CTC (Chicago Trading Company)’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-137,445
Closed -$3.65M 247
2024
Q4
$3.65M Sell
137,445
-58,784
-30% -$1.59M ﹤0.01% 186
2024
Q3
$5.68M Sell
196,229
-76,974
-28% -$2.25M ﹤0.01% 181
2024
Q2
$7.64M Sell
273,203
-121,813
-31% -$3.35M ﹤0.01% 199
2024
Q1
$11M Sell
395,016
-183,203
-32% -$5.08M 0.01% 211
2023
Q4
$16.6M Buy
578,219
+290,493
+101% +$8.78M 0.01% 204
2023
Q3
$9.54M Sell
287,726
-112,407
-28% -$3.97M 0.01% 237
2023
Q2
$14.7M Buy
400,133
+381,613
+2,061% +$14.9M 0.01% 233
2023
Q1
$748K Buy
+18,520
New +$800K ﹤0.01% 321
2022
Q3
Sell
-194,629
Closed -$9.46M 307
2022
Q2
$10.2M Sell
194,629
-199,343
-51% -$10.2M 0.01% 231
2022
Q1
$20.4M Sell
393,972
-971,054
-71% -$50.4M 0.01% 226
2021
Q4
$80.6M Buy
1,365,026
+813,977
+148% +$40.3M 0.03% 76
2021
Q3
$23.7M Buy
+551,049
New +$24.4M 0.01% 113
2013
Q3
Sell
-19,649
Closed -$522K 54
2013
Q2
$522K Buy
+19,649
New +$543K 0.04% 25

Other funds holding PFE

CTC (Chicago Trading Company)'s PFE Position: Q1 2025 in Review

CTC (Chicago Trading Company) sold out of Pfizer (PFE) in Q1 2025, closing a stake of 137,445 shares — an estimated $3.65M sold.

CTC (Chicago Trading Company) first reported a position in PFE in Q2 2013 and held it in 13 quarters. The position peaked at $80.6M in Q4 2021. 2,930 funds tracked by Wall St. Rank hold PFE as of Q1 2025.

  • CTC (Chicago Trading Company) reported no remaining Pfizer position as of Q1 2025 after selling out during the quarter.
  • CTC (Chicago Trading Company) sold 137,445 Pfizer shares in Q1 2025, an estimated $3.65M.
  • CTC (Chicago Trading Company) first reported a position in Pfizer in Q2 2013 and held it in 13 quarters.
  • CTC (Chicago Trading Company)'s Pfizer position peaked at $80.6M in Q4 2021.
  • 2,930 funds tracked by Wall St. Rank held Pfizer as of Q1 2025.

Based on CTC (Chicago Trading Company)'s 13F filing for Q1 2025, filed 16 May 2025.